Cancer of the cervix uteri: 2021 update
- PMID: 34669203
- PMCID: PMC9298213
- DOI: 10.1002/ijgo.13865
Cancer of the cervix uteri: 2021 update
Abstract
Since the publication of the 2018 FIGO Cancer Report, giant strides have been made in the global effort to reduce the burden of cervical cancer, with the World Health Organization (WHO) rolling out a global strategy for cervical cancer elimination, aiming for implementation by 2030. In over 130 countries, including low- and middle-income countries, HPV vaccination is now included in the national program. Screening has seen major advances with wider implementation of HPV testing. These interventions will take a few years to show their impact. Meanwhile, over half a million new cases are added each year. FIGO's revised staging of cervical cancer (2018) has been widely implemented and retrospective analyses of data based on the new staging have been published. Minimally invasive surgery has been shown to be disadvantageous in women with cervical cancer. This chapter discusses the management of cervical cancer based on the stage of disease, including attention to palliation and quality of life issues.
Keywords: FIGO Cancer Report; HPV vaccination; cancer; cervix; radiation; screening; staging; surgery.
International Journal of Gynecology & Obstetrics© 2021 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.
Conflict of interest statement
Outside of the submitted work, NB has received research funding through her institute from MSD, GlaxoSmithKline, and Digene/Qiagen Inc. Outside of the submitted work, DA has received honoraria from AstraZeneca, Chugai Pharmaceutical Co. Ltd., Eisai Co. Ltd, Taiho Pharmaceutical Co. Ltd, Coviden Japan Inc, Johnson & Johnson, and Takeda Pharmaceutical Co. Ltd; consulting fees from Takeda Pharmaceutical Co. Ltd, AstraZeneca, MSD, and Chugai Pharmaceutical Co. Ltd; and holds unpaid positions with the Asian Society of Gynecologic Oncology, Japan Society of Gynecologic Oncology, and the Japan Society of Obstetrics and Gynecology. RS advises on cancer prevention and early detection for Karkinos Healthcare Private Limited, a managed healthcare company in India. DNS has no conflicts of interest to declare.
Figures


References
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209‐249. - PubMed
-
- IARC Working Group . Human Papillomaviruses: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer. Accessed May 2, 2021. https://monographs.iarc.who.int/wp‐content/uploads/2018/06/mono90.pdf - PMC - PubMed
-
- Franco E, Villa L, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high‐risk area for cervical cancer. J Infect Dis. 1999;180:1415‐1423. - PubMed
-
- World Health Organization . Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. WHO; 2020. Accessed April 17, 2021. https://www.who.int/publications/i/item/9789240014107